N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142050 |
| CAS No | NA |
| Mol.F. | C6H6N6O3 |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142051 |
| CAS No | NA |
| Mol.F. | C6H6N6O3 |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142052 |
| CAS No | NA |
| Mol.F. | C12H16N6O7 |
| Mol.Wt. | 356.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142053 |
| CAS No | NA |
| Mol.F. | C6H8N6O3 |
| Mol.Wt. | 212.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142054 |
| CAS No | NA |
| Mol.F. | C7H7BrN2O |
| Mol.Wt. | 215.05 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142055 |
| CAS No | NA |
| Mol.F. | C7H8N2O2 |
| Mol.Wt. | 152.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142056 |
| CAS No | NA |
| Mol.F. | C13H13N3O2 |
| Mol.Wt. | 243.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142057 |
| CAS No | NA |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142058 |
| CAS No | NA |
| Mol.F. | C20H29N3O6 |
| Mol.Wt. | 407.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142059 |
| CAS No | NA |
| Mol.F. | C19H27N3O6 |
| Mol.Wt. | 393.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142060 |
| CAS No | 3050754-68-9 |
| Mol.F. | C29H26ClN7O4 |
| Mol.Wt. | 572 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142061 |
| CAS No | NA |
| Mol.F. | C13H12ClN3O2 |
| Mol.Wt. | 277.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142062 |
| CAS No | NA |
| Mol.F. | C24H19CLN6O3 |
| Mol.Wt. | 474.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142063 |
| CAS No | NA |
| Mol.F. | C30H28CLN7O5 |
| Mol.Wt. | 602 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142064 |
| CAS No | NA |
| Mol.F. | C30H28CLN7O6 |
| Mol.Wt. | 618 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142065 |
| CAS No | NA |
| Mol.F. | C15H13N5O2 |
| Mol.Wt. | 295.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |